Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Otsuka joins forces with IBM for Watson-based digital venture

Otsuka Digital Health will develop software to analyse psychiatric patient data

IBM Watson health pharma
IBM's Watson-based cognitive computing product for oncology (PRNewsFoto/IBM)

Otsuka and IBM have formed a digital health company in Japan that will develop and market specialist software to analyse psychiatric patient data.  

Known as Otsuka Digital Health, the partners' joint venture will formally established on Friday, with the pharma company taking an 85% stake in it to IBM Japan's 15%.  

The company has been set up to market MENTAT, software whose development was based on Otsuka's knowledge of central nervous system disorders and IBM's Watson-based technology.  

In a statement Otsuka said: “In psychiatry, patient symptoms and medical history are not usually enumerated and are entered into non-standardised electronic medical charts.  

“Therefore it takes significant time and effort for hospital medical staff to analyse and understand a large volume of records, and a massive of amount data is not used well.”  

The company hopes that its new digital health company and MENTAT software will enable hospital medical staff to use electronic medical records with more insight and, ultimate, provide better patient care.  

The venture will operate independently of Otsuka's pharmaceutical business, where its CNS interests, where it is one of the five-biggest companies in the world, thanks to products such as Abilify.

15th June 2016

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?